News
Wavelength Modulation Overcomes Obstacles to in-situ and in-vivo Use – Results Published in Biomedical Spectroscopy and Imaging
February 21, 2013 - Raman spectroscopy has enabled incredible advances in numerous scientific fields and is a powerful tool for tissue classification and disease recognition, although there have been considerable challenges to using the method in a clinical setting. Scientists have now demonstrated the advantages of wavelength-modulated Raman spectroscopy, opening the door to wider biomedical and clinical applications such as real-time assessment of tissues during surgery. This study is published in Biomedical Spectroscopy and Imaging.
More...
Findings Published in Restorative Neurology and Neuroscience
February 19, 2013 - Administration of the active compound tetrahydroxystilbene glucoside (TSG) derived from the Chinese herbal medicine Polygonum multiflorum Thunb, reversed both overexpression of α-synuclein, a small protein found in the brain, and its accumulation using a mouse model of Alzheimer’s disease. These results, which may shed light on the neuropathology of AD and open up new avenues of treatment, are available in the current issue of Restorative Neurology and Neuroscience.
More...
Scientists identify aromatic rice with very low arsenic content and higher concentrations of essential nutrients, selenium and zinc – published in Biomedical Spectroscopy and Imaging
February 18, 2013 - Millions of people worldwide are regularly exposed to arsenic through drinking water and eating rice grown in soil and water containing high amounts of arsenic. Long-term exposure can lead to the development of different types of cancer as well as serious cardiovascular, neurological, and other health problems. Scientists have now identified aromatic rice from Bangladesh that has far lower arsenic concentrations than found in non-aromatic rice. The other important benefit is that it contains higher amounts of selenium and zinc. The discovery is reported in Biomedical Spectroscopy and Imaging.
More...
Cost remains prohibitive factor, but OHSU survey finds experts believe the scan can help with diagnosis
February 14, 2013 - A large majority of the nation's top neurologists say they would use a recently approved amyloid detection brain scan to evaluate their patients for Alzheimer's disease if the scan was paid for by health insurance, according to a survey recently published in the Journal of Alzheimer's Disease.
More...
